Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about ...

Black box labels on the medications — which are prescribed to treat menopause symptoms — warn of serious risks like breast ...

The decision, issued without the input of an official advisory committee, revises long-held labeling on the drugs cautioning ...

The FDA is reversing a 2003 decision that put a stringent warning on hormone therapy products for menopausal women, saying ...

The Food and Drug Administration is removing the “black box” warnings from hormone replacement therapy products for menopause ...

Health and Human Services Secretary Robert F. Kennedy Jr. said the warnings about stroke, heart attack, dementia and blood ...

In a pivotal move, the US Food and Drug Administration has changed // done away with the lengthy black box warning on many hormone treatments for women with menopause symptoms.

The benefits of hormone replacement have been underappreciated, Dr. Marty Makary, the agency’s commissioner, said on Monday. Critics described evidence for the change as insufficient.

Hormone therapy drugs have carried box warning labels for years. Food and Drug Administration Commissioner Marty Makary talks ...

Early population studies, such as the seminal Framingham Heart Study, represented a moment of hope. However, initial analyses ...

"In general, health care was designed by men for men," says Stacey Rosen, president of the American Heart Association. She ...